Meridia, Sibutramine Wire
Comprehensive News Feed for Meridia, Sibutramine (generic).
Results 1 - 20 of 250 in Meridia, Sibutramine (generic)
-
FDA Reviews Safety of Diet Drug Meridia
Nov. 23, 2009 -- A new study of the weight loss drug Meridia is in the hands of FDA regulators, who've released an early communication based on preliminary data: certain patients taking the drug may have a higher risk of heart attacks , strokes, and other serious cardiovascular problems. Comment?
-
Sibutramine May Increase Cardiovascular-Event Risk
Preliminary data from a placebo-controlled, 10,000-patient study suggest that the antiobesity drug sibutramine may increase patients' risk of cardiovascular adverse events, FDA announced on Friday. Comment?
-
FDA MedWatch - Meridia (sibutramine): Early Communication about cardiovascular events
ROCKVILLE, Nov. 21, 2009-FDA notified healthcare professionals and patients that it is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events than patients using a placebo . Comment?
-
FDA Investigating Possible Link Between Sibutramine and Cardiovascular Events
The FDA has issued an early communication regarding a possible increased risk for adverse cardiovascular events associated with sibutramine , a prescription drug used to manage obesity. Comment?
-
FDA investigates popular weight loss drug, Meridia
w/Photo
The Food and Drug Administration is investigating the possibility that the weight loss drug, Meridia , may increase the risks of cardiovascular events. Comment?
-
Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review
Sibutramine is marketed as Meridia, a prescription drug, in the United States. Meridia was approved by FDA in 1997 for the management of obesity, including weight loss and maintenance of weight loss, in conjunction with a reduced calorie diet. Comment?
-
Dietary Supplement recall
w/Photo
GMP Herbal Products Inc. is recalling Pai You Guo, a weight loss dietary supplement, because it contains drug ingredients not declared on the label. Comment?
-
Health News: Exclusive: Record numbers of Scots being prescribed anti-obesity drugs
RECORD numbers of obese Scots are being given fat-busting drugs costing 4million a year. Comment?
-
The U.S. Food and Drug Administration is conducting a review of the weight loss medication sibutramine, marketed in prescription form as Meridia, due to a recent study suggesting heart problems may be associated with the medication. Comment?
-
US REGULATORS are reviewing preliminary data suggesting patients taking Abbott Laboratories Inc's weight loss drug Meridia may have a higher risk of cardiovascular problems, the Food and Drug Administration said on Friday. Comment?
-
Early Communication about an Ongoing Safety Review of Meridia
w/Photo
Early Communication about an Ongoing Safety Review ofA A Meridia This information reflects FDA's current analysis of available data concerning this drug. Comment?
-
Abbott's diet drug's risks have FDA's attention
"The analysis of these data is ongoing and FDA is making no conclusions about the preliminary findings at this time," the agency said in a statement. Comment?
-
More studies needed on possible fibromyalgia drug
DEAR DR. GOTT: I am writing to you because of your willingness to share information on remedies that have been reported successful by your readers. Comment?
-
GMP Herbal Products Inc. is recalling Pai You Guo, a weight loss dietary supplement, because it contains drug ingredients not declared on the label. Comment?
-
FDA targets GMP Herbal Products over weight-loss dietary supplement
WESTMINSTER,A Calif. The Food and Drug Administration moved against another online marketer purporting to sell a dietary supplement weight-loss product last week. Comment?
-
Pai You Guo Weight Loss Supplement Recalled
The U.S. Food and Drug Administration informed GMP Herbal Products, Inc. that its weight loss dietary supplement, sold and marketed as Pai You Guo, contains undeclared ingredients. Comment?
-
FDA targets GMP Herbal Products over weight loss dietary supplement
WESTMINSTER,A Calif. The Food and Drug Administration moved against another online marketer purporting to sell a dietary supplement weight-loss product last week. Comment?
-
Doctor admits forging drug prescriptions for herself
A young doctor has admitted to forging prescriptions for weight-loss drugs to help keep her awake during long working hours. Comment?
-
Pai You Guo, Marketed as Dietary Supplement - Recall
FDA lab analyses of dietary supplements were found to contain undeclared sibutramine, an FDA-approved drug used as an appetite suppressant for weight loss; and phenolphthalein, a solution used in chemical experiments and a suspected cancer-causing agent that is not approved for marketing in the United States. Comment?
-
California Company Recalls Weight Loss Supplement
A California company has recalled a weight loss supplement because it contains two undeclared ingredients that pose a health risk. Comment?
Meridia, Sibutramine Forum
Most Popular
- Jesse Jackson Says Black Men 'Can't Vote Against Healthcare', Media Mostly Mum - 248 comments
- Being gay is not a choice. What if it were? - 240 comments
- Texas kid beaten with metal pole, entirely preventable - 191 comments
- Historic health care bill clears Senate hurdle - 183 comments
- Dr. Paolo Zamboni at his research lab at the University of Ferrara - 71 comments
- Obama inspires; Palin connects - 118 comments
- Anti-Obama billboard in suburban Denver, Colorado stirs controversy; asks for... - 142 comments
- Woman Loses Disability Insurance Over Facebook Photos - 125 comments
- Defense Attorney: Hasan Is Paralyzed From the Chest Down - 103 comments
- Woman Arrested After Cutting Line Claims Racism - 61 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
